×

Our award-winning reporting has moved

Context provides news and analysis on three of the world’s most critical issues:

climate change, the impact of technology on society, and inclusive economies.

BRIEF-U.S. Government Medicare Program Plans To Cover Alzheimer's Treatments Including Biogen's Aduhelm With Conditions

by Reuters
Tuesday, 11 January 2022 22:04 GMT

Jan 11 (Reuters) - CMS:

* U.S. GOVERNMENT MEDICARE PROGRAM PLANS TO COVER ALZHEIMERS TREATMENTS INCLUDING BIOGEN'S ADUHELM WITH CONDITIONS

* U.S. GOVERNMENT MEDICARE PROGRAM PROPOSES THAT COMPANIES MAKING ALZHEIMERS DRUGS MUST RUN ADDITIONAL TRIALS Further company coverage:

Our Standards: The Thomson Reuters Trust Principles.

-->